Skip to main content
TipRanks
Go Ultimate75% OFF

CHA AI Healthkare Co.,Ltd. (025620) Ratios

CHA AI Healthkare Co.,Ltd. Ratios

KR:025620's free cash flow for Q3 2026 was ₩-1.92B. For the 2026 fiscal year, KR:025620's free cash flow was increased by ₩0.00 and operating cash flow was ₩-1.92B. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio1.491.432.273.481.40
Quick Ratio1.401.131.873.211.12
Cash Ratio1.160.230.581.640.43
Solvency Ratio0.06-0.96-0.73-3.06-1.87
Operating Cash Flow Ratio-0.20-0.78-1.20-0.78-0.18
Short-Term Operating Cash Flow Coverage-0.23-1.62-4.68-2.34-0.48
Net Current Asset Valueâ‚© 15.93Bâ‚© 3.46Bâ‚© 10.22Bâ‚© 15.53Bâ‚© 6.94B
Leverage Ratios
Debt-to-Assets Ratio0.280.140.060.060.11
Debt-to-Equity Ratio0.410.180.070.070.14
Debt-to-Capital Ratio0.290.150.070.060.13
Long-Term Debt-to-Capital Ratio0.000.010.000.010.00
Financial Leverage Ratio1.461.311.211.161.34
Debt Service Coverage Ratio-0.23-2.08-3.99-10.65-1.81
Interest Coverage Ratio-7.11-44.32-78.83-16.46-10.44
Debt to Market Cap0.150.270.100.150.12
Interest Debt Per Share1738.521209.02668.091146.693521.09
Net Debt to EBITDA1.30-0.420.220.42-0.02
Profitability Margins
Gross Profit Margin18.27%46.90%49.60%14.48%4.78%
EBIT Margin-105.24%-52.06%-59.50%-127.81%-121.07%
EBITDA Margin-95.10%-48.44%-55.32%-295.32%-109.43%
Operating Profit Margin-105.44%-34.74%-63.10%-127.76%-121.07%
Pretax Profit Margin18.71%-52.84%-42.19%-312.37%-239.87%
Net Profit Margin18.71%-60.56%-42.25%-343.16%-258.21%
Continuous Operations Profit Margin18.71%-62.53%-37.09%-312.37%-239.59%
Net Income Per EBT100.00%114.60%100.14%109.86%107.65%
EBT Per EBIT-17.75%152.10%66.85%244.50%198.13%
Return on Assets (ROA)1.24%-24.39%-14.06%-44.30%-48.41%
Return on Equity (ROE)1.81%-32.02%-16.99%-51.53%-64.70%
Return on Capital Employed (ROCE)-10.12%-18.15%-25.28%-19.01%-29.83%
Return on Invested Capital (ROIC)-7.27%-15.59%-23.74%-18.00%-26.31%
Return on Tangible Assets1.25%-24.51%-14.15%-44.45%-53.25%
Earnings Yield0.70%-55.26%-29.21%-127.96%-63.94%
Efficiency Ratios
Receivables Turnover1.443.2815.890.6719.78
Payables Turnover5.27123.735.3016.346.06
Inventory Turnover2.013.122.503.032.67
Fixed Asset Turnover4.6413.2322.817.148.97
Asset Turnover0.070.400.330.130.19
Working Capital Turnover Ratio0.722.211.220.53-22.15
Cash Conversion Cycle365.33225.27100.07640.3094.76
Days of Sales Outstanding252.82111.3822.98542.3818.45
Days of Inventory Outstanding181.81116.84146.02120.27136.51
Days of Payables Outstanding69.302.9568.9322.3460.19
Operating Cycle434.63228.22169.00662.64154.96
Cash Flow Ratios
Operating Cash Flow Per Share-368.70-1545.25-2263.31-1763.57-1188.76
Free Cash Flow Per Share-368.70-1599.81-2283.08-4590.56-3264.92
Dividend Paid and CapEx Coverage Ratio-1677970846.00-28.33-114.50-0.62-0.57
Capital Expenditure Coverage Ratio-1677970846.00-28.33-114.50-0.62-0.57
Operating Cash Flow Coverage Ratio-0.22-1.31-3.54-1.81-0.41
Operating Cash Flow to Sales Ratio-0.92-0.44-0.61-0.80-0.23
Free Cash Flow Yield-3.46%-41.66%-42.75%-77.41%-15.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio58.90-1.81-3.42-0.78-1.56
Price-to-Sales (P/S) Ratio26.561.101.452.684.04
Price-to-Book (P/B) Ratio2.570.580.580.401.01
Price-to-Free Cash Flow (P/FCF) Ratio-28.91-2.40-2.34-1.29-6.31
Price-to-Operating Cash Flow Ratio-28.91-2.49-2.36-3.36-17.33
Price-to-Earnings Growth (PEG) Ratio-0.54-0.050.040.02-0.02
Enterprise Value Multiple-26.64-2.69-2.39-0.49-3.71
Enterprise Value185.05B20.39B21.31B9.00B60.78B
EV to EBITDA-26.64-2.69-2.39-0.49-3.71
EV to Sales25.331.301.321.444.06
EV to Free Cash Flow-27.57-2.85-2.14-0.69-6.34
EV to Operating Cash Flow-27.57-2.95-2.16-1.81-17.41
Tangible Book Value Per Share4101.446581.629103.1314663.3918011.74
Shareholders’ Equity Per Share4144.236627.269180.6914724.6520359.77
Tax and Other Ratios
Effective Tax Rate0.00-0.18-0.00-0.48-0.00
Revenue Per Share401.293503.643692.742211.245101.43
Net Income Per Share75.09-2121.85-1560.00-7588.09-13172.56
Tax Burden1.001.151.001.101.08
Interest Burden-0.181.020.712.441.98
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.720.701.071.321.18
Stock-Based Compensation to Revenue0.000.000.00-0.000.00
Income Quality-4.910.731.450.230.09

Currency in KRW